Douglass Winthrop Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.4M Sell
103,834
-4,513
-4% -$1.05M 0.46% 37
2025
Q4
$22.4M Buy
108,347
+902
+0.8% +$178K 0.39% 38
2025
Q3
$19.9M Buy
107,445
+10,364
+11% +$1.78M 0.35% 39
2025
Q2
$14.8M Sell
97,081
-1,343
-1% -$206K 0.27% 41
2025
Q1
$16.3M Sell
98,424
-10,985
-10% -$1.72M 0.31% 37
2024
Q4
$15.8M Buy
109,409
+2,357
+2% +$365K 0.31% 38
2024
Q3
$17.3M Buy
107,052
+4,609
+4% +$734K 0.33% 37
2024
Q2
$15M Sell
102,443
-9,994
-9% -$1.49M 0.31% 39
2024
Q1
$17.8M Sell
112,437
-1,850
-2% -$294K 0.37% 37
2023
Q4
$17.9M Sell
114,287
-1,940
-2% -$297K 0.4% 36
2023
Q3
$18.1M Buy
116,227
+42
+0% +$6.93K 0.45% 37
2023
Q2
$19.2M Sell
116,185
-1,432
-1% -$231K 0.46% 36
2023
Q1
$18.2M Sell
117,617
-7,545
-6% -$1.22M 0.47% 36
2022
Q4
$22.1M Buy
125,162
+895
+0.7% +$155K 0.61% 34
2022
Q3
$20.3M Sell
124,267
-1,729
-1% -$293K 0.61% 33
2022
Q2
$22.4M Sell
125,996
-270
-0.2% -$48.1K 0.63% 34
2022
Q1
$22.4M Sell
126,266
-2,279
-2% -$388K 0.53% 35
2021
Q4
$22M Sell
128,545
-1,673
-1% -$274K 0.49% 35
2021
Q3
$21M Buy
130,218
+2,267
+2% +$387K 0.52% 35
2021
Q2
$21.1M Sell
127,951
-3,160
-2% -$523K 0.52% 36
2021
Q1
$21.5M Sell
131,111
-1,195
-0.9% -$193K 0.58% 35
2020
Q4
$20.8M Buy
132,306
+1,026
+0.8% +$151K 0.59% 34
2020
Q3
$19.5M Buy
131,280
+3,155
+2% +$467K 0.64% 35
2020
Q2
$18M Buy
128,125
+3,990
+3% +$581K 0.67% 35
2020
Q1
$16.3M Sell
124,135
-23,458
-16% -$3.33M 0.73% 34
2019
Q4
$21.5M Sell
147,593
-3,381
-2% -$459K 0.76% 34
2019
Q3
$19.5M Sell
150,974
-9,375
-6% -$1.24M 0.75% 35
2019
Q2
$22.3M Sell
160,349
-2,689
-2% -$372K 0.9% 34
2019
Q1
$22.8M Sell
163,038
-12,616
-7% -$1.69M 0.99% 34
2018
Q4
$22.7M Buy
175,654
+1,959
+1% +$273K 1.13% 33
2018
Q3
$24M Sell
173,695
-35,506
-17% -$4.72M 1.06% 34
2018
Q2
$25.4M Sell
209,201
-2,081
-1% -$260K 1.14% 32
2018
Q1
$27.1M Buy
211,282
+11,928
+6% +$1.61M 1.32% 29
2017
Q4
$27.9M Buy
199,354
+1,578
+0.8% +$220K 1.52% 26
2017
Q3
$25.7M Sell
197,776
-2,953
-1% -$391K 1.49% 26
2017
Q2
$26.6M Sell
200,729
-12,274
-6% -$1.57M 1.61% 27
2017
Q1
$26.5M Sell
213,003
-4,457
-2% -$532K 1.65% 25
2016
Q4
$25.1M Sell
217,460
-1,779
-0.8% -$205K 1.69% 24
2016
Q3
$25.9M Sell
219,239
-3,029
-1% -$367K 1.79% 23
2016
Q2
$27M Buy
222,268
+850
+0.4% +$96.6K 1.9% 22
2016
Q1
$24M Sell
221,418
-3,500
-2% -$362K 1.73% 24
2015
Q4
$23.1M Buy
224,918
+2,435
+1% +$245K 1.71% 20
2015
Q3
$20.8M Buy
222,483
+718
+0.3% +$69.5K 1.64% 22
2015
Q2
$22.3M Hold
221,765
1.73% 21
2015
Q1
$22.3M Buy
221,765
+58,207
+36% +$5.92M 1.73% 21
2014
Q4
$17.1M Sell
163,558
-123
-0.1% -$13K 1.52% 23
2014
Q3
$17.4M Buy
163,681
+2,028
+1% +$210K 1.61% 26
2014
Q2
$16.9M Sell
161,653
-1,033
-0.6% -$104K 1.56% 27
2014
Q1
$16M Buy
162,686
+6,720
+4% +$623K 1.58% 26
2013
Q4
$14.3M Buy
155,966
+4,198
+3% +$387K 1.48% 28
2013
Q3
$13.2M Buy
151,768
+1,309
+0.9% +$117K 1.53% 28
2013
Q2
$12.9M Buy
+150,459
New +$12.8M 1.56% 27

Other funds holding JNJ

Douglass Winthrop Advisors's JNJ Position: Q1 2026 in Review

Douglass Winthrop Advisors reduced its Johnson & Johnson (JNJ) stake by 4.2% in Q1 2026, selling an estimated $1.05M and leaving 103,834 shares worth $25.4M. The position accounts for 0.46% of the portfolio, ranked #37.

Douglass Winthrop Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.9M in Q4 2017. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Douglass Winthrop Advisors held 103,834 shares of Johnson & Johnson worth $25.4M as of Q1 2026.
  • Douglass Winthrop Advisors sold 4,513 Johnson & Johnson shares in Q1 2026, an estimated $1.05M.
  • Johnson & Johnson made up 0.46% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #37 holding.
  • Douglass Winthrop Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Douglass Winthrop Advisors's Johnson & Johnson position peaked at $27.9M in Q4 2017.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.